206 related articles for article (PubMed ID: 18430455)
1. Biliary neoplasia with extensive intraductal spread associated with liver cirrhosis: a hitherto unreported variant of biliary intraepithelial neoplasia.
Aishima S; Nishihara Y; Tsujita E; Taguchi K; Soejima Y; Taketomi A; Ikeda Y; Maehara Y; Tsuneyoshi M
Hum Pathol; 2008 Jun; 39(6):939-47. PubMed ID: 18430455
[TBL] [Abstract][Full Text] [Related]
2. Biliary intraepithelial neoplasia in patients without chronic biliary disease: analysis of liver explants with alcoholic cirrhosis, hepatitis C infection, and noncirrhotic liver diseases.
Wu TT; Levy M; Correa AM; Rosen CB; Abraham SC
Cancer; 2009 Oct; 115(19):4564-75. PubMed ID: 19670455
[TBL] [Abstract][Full Text] [Related]
3. Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct--an immunohistochemical study of 110 cases of hepatolithiasis.
Zen Y; Sasaki M; Fujii T; Chen TC; Chen MF; Yeh TS; Jan YY; Huang SF; Nimura Y; Nakanuma Y
J Hepatol; 2006 Feb; 44(2):350-8. PubMed ID: 16360234
[TBL] [Abstract][Full Text] [Related]
4. Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm.
Nakanishi Y; Zen Y; Kondo S; Itoh T; Itatsu K; Nakanuma Y
Hum Pathol; 2008 Aug; 39(8):1153-61. PubMed ID: 18495210
[TBL] [Abstract][Full Text] [Related]
5. Primary liver carcinoma in genetic hemochromatosis reveals a broad histologic spectrum.
Morcos M; Dubois S; Bralet MP; Belghiti J; Degott C; Terris B
Am J Clin Pathol; 2001 Nov; 116(5):738-43. PubMed ID: 11710692
[TBL] [Abstract][Full Text] [Related]
6. Bile duct changes in different etiologic types of end-stage chronic liver disease: a study on native explant livers.
Jain D; Nayak NC
J Clin Pathol; 2012 Apr; 65(4):348-51. PubMed ID: 22135029
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification.
Akiba J; Nakashima O; Hattori S; Tanikawa K; Takenaka M; Nakayama M; Kondo R; Nomura Y; Koura K; Ueda K; Sanada S; Naito Y; Yamaguchi R; Yano H
Am J Surg Pathol; 2013 Apr; 37(4):496-505. PubMed ID: 23388123
[TBL] [Abstract][Full Text] [Related]
8. [Expression of mucin glycoproteins and cytokeratins in intrahepatic cholangiocarcinoma].
Zhao SM; Zhu XZ; Ji Y; Hou J
Zhonghua Bing Li Xue Za Zhi; 2008 Nov; 37(11):749-53. PubMed ID: 19094709
[TBL] [Abstract][Full Text] [Related]
9. Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules.
Kwon Y; Lee SK; Kim JS; Ro JY; Yu E
Mod Pathol; 2002 Oct; 15(10):1096-101. PubMed ID: 12379757
[TBL] [Abstract][Full Text] [Related]
10. Bile duct dysplasia in the setting of chronic hepatitis C and alcohol cirrhosis.
Torbenson M; Yeh MM; Abraham SC
Am J Surg Pathol; 2007 Sep; 31(9):1410-3. PubMed ID: 17721197
[TBL] [Abstract][Full Text] [Related]
11. Increased MUC6 apomucin expression is a characteristic of reactive biliary epithelium in chronic viral hepatitis.
Sasaki M; Nakanuma Y; Ho SB; Kim YS
J Pathol; 1998 Jun; 185(2):191-8. PubMed ID: 9713347
[TBL] [Abstract][Full Text] [Related]
12. Combined hepatocellular carcinoma and cholangiocarcinoma with components of mucinous carcinoma arising in a cirrhotic liver.
Morita D; Kagata Y; Ogata S; Tsuda H; Hatsuse K; Mochizuki H; Matsubara O
Pathol Int; 2006 Apr; 56(4):222-6. PubMed ID: 16634969
[TBL] [Abstract][Full Text] [Related]
13. Two distinct pathways of carcinogenesis in primary sclerosing cholangitis.
Zen Y; Quaglia A; Heaton N; Rela M; Portmann B
Histopathology; 2011 Dec; 59(6):1100-10. PubMed ID: 22175890
[TBL] [Abstract][Full Text] [Related]
14. Intraductal papillary cholangiocarcinoma and atypical biliary epithelial lesions confused with intrabiliary extension of metastatic colorectal carcinoma.
Itatsu K; Fujii T; Sasaki M; Zen Y; Nakanuma Y
Hepatogastroenterology; 2007; 54(75):677-80. PubMed ID: 17591040
[TBL] [Abstract][Full Text] [Related]
15. Increasing expression of gastrointestinal phenotypes and p53 along with histologic progression of intraductal papillary neoplasia of the liver.
Shimonishi T; Zen Y; Chen TC; Chen MF; Jan YY; Yeh TS; Nimura Y; Nakanuma Y
Hum Pathol; 2002 May; 33(5):503-11. PubMed ID: 12094375
[TBL] [Abstract][Full Text] [Related]
16. A histopathological study on combined hepatocellular and cholangiocarcinoma: cholangiocarcinoma component is originated from hepatocellular carcinoma.
Wakasa T; Wakasa K; Shutou T; Hai S; Kubo S; Hirohashi K; Umeshita K; Monden M
Hepatogastroenterology; 2007 Mar; 54(74):508-13. PubMed ID: 17523309
[TBL] [Abstract][Full Text] [Related]
17. Primary liver cancer with dual expression of hepatocyte and bile duct epithelial markers.
Uenishi T; Hirohashi K; Shuto T; Tsukamoto T; Yamamoto T; Ogawa M; Kubo S; Tanaka H; Kinoshita H
Hepatogastroenterology; 2002; 49(46):1092-4. PubMed ID: 12143210
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic value of cytokeratins and carcinoembryonic antigen immunostaining in differentiating hepatocellular carcinomas from intrahepatic cholangiocarcinomas.
Stroescu C; Herlea V; Dragnea A; Popescu I
J Gastrointestin Liver Dis; 2006 Mar; 15(1):9-14. PubMed ID: 16680226
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Glut-1 expression in cholangiocarcinoma, benign biliary lesions and hepatocellular carcinoma.
Zimmerman RL; Fogt F; Burke M; Murakata LA
Oncol Rep; 2002; 9(4):689-92. PubMed ID: 12066193
[TBL] [Abstract][Full Text] [Related]
20. Intraperitoneal rupture of cholangiocarcinoma in a patient with liver cirrhosis, type C, with hepatocellular carcinoma.
Watanabe M; Akagi S; Hamamoto S
Am J Gastroenterol; 1999 Aug; 94(8):2320-1. PubMed ID: 10445582
[No Abstract] [Full Text] [Related]
[Next] [New Search]